RPS6KB1 and metabolic dysfunction-associated steatohepatitis: In this case, protein kinase B (Akt) and p70S6 Kinase (P70S6K) phosphorylation are decreased and circulating inflammatory cytokines increase developing a nonalcoholic steatohepatitis (NASH) (16–19).